Zurich Cantonal Bank’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-4,395
| Closed | -$126K | – | 2596 |
|
|
2018
Q4 | $126K | Hold |
4,395
| – | – | ﹤0.01% | 1464 |
|
|
2018
Q3 | $123K | Buy |
4,395
+683
| +18% | +$19.2K | ﹤0.01% | 1600 |
|
|
2018
Q2 | $104K | Hold |
3,712
| – | – | ﹤0.01% | 1623 |
|
|
2018
Q1 | $92K | Hold |
3,712
| – | – | ﹤0.01% | 1647 |
|
|
2017
Q4 | $90K | Buy |
3,712
+797
| +27% | +$21K | ﹤0.01% | 1636 |
|
|
2017
Q3 | $80K | Hold |
2,915
| – | – | ﹤0.01% | 1523 |
|
|
2017
Q2 | $73K | Buy |
2,915
+334
| +13% | +$8.27K | ﹤0.01% | 1541 |
|
|
2017
Q1 | $69K | Hold |
2,581
| – | – | ﹤0.01% | 1588 |
|
|
2016
Q4 | $68K | Buy |
2,581
+1,103
| +75% | +$27.3K | ﹤0.01% | 1532 |
|
|
2016
Q3 | $37K | Buy |
1,478
+273
| +23% | +$6.37K | ﹤0.01% | 1849 |
|
|
2016
Q2 | $26K | Hold |
1,205
| – | – | ﹤0.01% | 1920 |
|
|
2016
Q1 | $18K | Hold |
1,205
| – | – | ﹤0.01% | 2141 |
|
|
2015
Q4 | $26K | Buy |
1,205
+519
| +76% | +$9.67K | ﹤0.01% | 1875 |
|
|
2015
Q3 | $11K | Buy |
686
+396
| +137% | +$6.35K | ﹤0.01% | 1949 |
|
|
2015
Q2 | $4K | Hold |
290
| – | – | ﹤0.01% | 2103 |
|
|
2015
Q1 | $5K | Buy |
+290
| New | +$5.12K | ﹤0.01% | 1982 |
|
Other funds holding NXTM
Zurich Cantonal Bank's NXTM Position: Q1 2019 in Review
Zurich Cantonal Bank sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 4,395 shares — an estimated $126K sold.
Zurich Cantonal Bank first reported a position in NXTM in Q1 2015 and held it in 16 quarters. The position peaked at $126K in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Zurich Cantonal Bank reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Zurich Cantonal Bank sold 4,395 NxStage Medical Inc. shares in Q1 2019, an estimated $126K.
- Zurich Cantonal Bank first reported a position in NxStage Medical Inc. in Q1 2015 and held it in 16 quarters.
- Zurich Cantonal Bank's NxStage Medical Inc. position peaked at $126K in Q4 2018.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Zurich Cantonal Bank's 13F filing for Q1 2019, filed 29 Apr 2019.